According to the Renub Research report “Autoimmune Disease Diagnostic Market, By Disease, Regions, Tests Type, Global Forecast” the Autoimmune Disease Diagnostic Market is forecasted to exceed US$ 18 Billion by the end of the year 2025.
Increasing awareness of autoimmune diseases through research, training, aid, and advocacy services is a crucial factor that globally boosts the usage rates of autoimmune disease diagnostics. The United States has the highest incidence of autoimmune diseases; about 50 million patients are suffering from this disease.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=autoimmune-disease-diagnostic-market-p.php
In the year 2017, roughly 54.4 Million people in the United States suffer from diagnosed arthritis, according to the Arthritis Foundation. According to the International Diabetes Federation (IDF)’s 2017 study, approximately 425 million adults (20-79 years) had diabetes, and this figure could grow to 629 Million worldwide by 2045.
Government organizations and NGOs are aiming to raise awareness of the socio-economic impact of autoimmunity by encouraging and fostering effective, ethical, and productive cooperation in the fields of health, public awareness, research, and patient care.
Certain factors, such as increased laboratory automation, collaborations with doctors and medical clinics, and advances in technology, drive the diagnostics demand for autoimmune disease. But, the slow diagnostic turnaround time and the high frequency of false results impede the growth of the diagnostic market for autoimmune disease.
Autoimmunity includes the failure of normal immune homeostasis as an abnormal response to its own tissue is produced by the tissue. Autoimmune diseases generally involve the presence of self-reactive T cells, inflammation, and auto-antibodies. It is challenging to diagnose possible autoimmune diseases, as not a single laboratory test alone can provide conclusive results for the condition. Therefore, there is a need for several laboratory tests, including basic studies such as acute phase reactants, flow cytometry, cytokine analysis, complete blood count, comprehensive metabolic panel, serologies, immunologic studies, and HLA typing.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=autoimmune-disease-diagnostic-market-p.php
Although some measurements, such as the erythrocyte sedimentation rate (ESR), maybe non-specific, they are useful for evaluating disease activity. Such tests can help diagnose and treat patients with autoimmune diseases and help to provide a prognosis or indicate the extent of organ involvement or damage.
By Disease: Market and market share of Systemic Autoimmune Disease (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), and others) and Localized Autoimmune Disease Diagnostics (Inflammatory Bowel Disease, Type 1 Diabetes, Thyroid, and other Localized Autoimmune Diseases) are given in this research report.
By Tests Type: Market of Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, and others are given in the report.
By Region: North America, Europe, Asia-Pacific & Rest of World regions are covered with market and market share in the report.
By Companies: Overview, Business Strategy, and Financial Insights of Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic, and Bio-Rad Laboratories are provided in the report.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Key Topics Covered :
1. Executive Summary
2. Global Autoimmune Diseases Diagnostic Market
3. Market Share – Global Autoimmune Diseases Diagnostic
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. By Disease – Global Autoimmune Diseases Diagnostic Market
4.1 Systemic Autoimmune Disease
4.2 Localized Autoimmune Disease Diagnostics
5. By Test Type – Global Autoimmune Diseases Diagnostic Market
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. By Region – Global Autoimmune Diseases Diagnostic Market
6.1 North America
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. Abbott Laboratories – Company Analysis
7.2 Business Strategy
7.3 Financial Insight
8. Siemens Healthineers – Company Analysis
8.2 Business Strategy
8.3 Financial Insight
9. Roche Diagnostics – Company Analysis
9.2 Roche Holding AG Key Development
9.3 Business Strategy
9.4 Financial Insight
10. EUROIMMUN AG – Company Analysis
10.2 Business Strategy
11. bioMerieux SA – Company Analysis
11.2 Business Strategy
11.3 Financial Insight
12. Quest Diagnostic – Company Analysis
12.2 Business Strategy
12.3 Financial Insight
13. Bio-Rad Laboratories – Company Analysis
13.2 Business Strategy
13.3 Financial Insight
14. Growth Drivers
14.1 Rising Incidence of Autoimmune Diseases
14.2 High Occurrence of Rheumatoid Arthritis
15.1 Industry Challenges by Product Differentiation
15.2 High Costs of Equipment for Diagnosis of Autoimmune Diseases
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Follow us on LinkedIn: www.linkedin.com/company/renub-research